Ireland· IE-PA-EU/1/02/222/001
Tamiflu 75 mg hard capsules
A oseltamivir product containing oseltamivir phosphate, registered in Ireland by Roche Registration GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Oseltamivir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AH02 (oseltamivir), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Oseltamivir · ATC J05AH02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Oseltamivir phosphate
- Manufacturer
- Roche Registration GmbH
- Country
- Ireland (IE)
- ATC code
- J05AH02
- ATC class
- Oseltamivir
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/02/222/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
93 interactions on record for oseltamivir.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oseltamivir · interactions on record
93 records
- 4 moderate
- 1 minor
- 88 info
Most severe, free to view
- MethotrexateL01BA01moderate
- PemetrexedL01BA04moderate
- MethotrexateL04AX03moderate
- MethotrexatM01CX01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oseltamivir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesoseltamavir phosphateProficient Rx LP
- PolandEbilfuminActavis Group PTC ehf.
- United KingdomEbilfumin 75mg capsulesTeva UK Ltd
- CanadaJAMP OSELTAMIVIRJAMP PHARMA CORPORATION
- SpainEBILFUMIN 75 MG CAPSULAS DURAS EFGActavis Group Ptc Ehf.
- NetherlandsEbilfumin 75 mg, harde capsuleActavis Group PTC ehf
- FinlandEbilfuminActavis Group PTC ehf
- CzechiaEBILFUMINActavis Group PTC ehf., Hafnarfjördur
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Bulgaria · Бетафлу
- Germany · Oseltamivir Hec Pharm, Oseltamivir Stada
- Estonia · Segosana
- Spain · Oseltamivir Accord
- France · Oseltamivir Zentiva
- United Kingdom (Northern Ireland) · Oseltamivir, Oseltamivir Accord-Uk
- Hungary · Segosana
- Iceland · Ebilfumin, Tamiflu
- Liechtenstein · Ebilfumin, Tamiflu
- Lithuania · Segosana
- Latvia · Segosana
- Netherlands · Oseltamivir Zentiva, Segosana
- Norway · Ebilfumin, Tamiflu
- Poland · Griptavir Med, Oseltamivir Stada
- Romania · Oseltamivir Accord, Oseltamivir Laropharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e78e808f-9867-44e4-8b55-17fe18f06c1e GET /v1/drugs/e78e808f-9867-44e4-8b55-17fe18f06c1e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J05AH02"
],
"strength": null,
"pa_number": "EU/1/02/222/001",
"substances": [
"Oseltamivir phosphate"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about oseltamivir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.